טוען...

Low dose IL-2 for In Vivo Expansion of CD4(+) and CD8(+) Regulatory T Cells in Nonhuman Primates

IL-2 is a known potent T cell growth factor that amplifies lymphocyte responses in vivo. This capacity has led to the use of high dose IL-2 to enhance T cell immunity in patients with AIDS or cancer. However, more recent studies have indicated that IL-2 is also critical for the development and perip...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Aoyama, A., Klarin, D., Yamada, Y., Boskovic, S., Nadazdin, O., Kawai, K., Schoenfeld, D., Madsen, J. C., Cosimi, A.B., Benichou, G., Kawai, T.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429727/
https://ncbi.nlm.nih.gov/pubmed/22682297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2012.04133.x
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!